completing < complex < complexation

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 37.
[0-20] [0 - 20][0 - 37][20-36][20-40]

Ident.	Authors (with country if any)	Title
000009 (2008)	Misato Hashizume [Japon] ; Masahiko Mihara [Japon]	Influence of humanized anti-IL-6R antibody, tocilizumab on the activity of soluble gp130, natural inhibitor of IL-6 signaling
000031 (2005)	Shumpei Yokota [Japon] ; Takako Miyamae [Japon] ; Tomoyuki Imagawa [Japon] ; Shigeki Katakura [Japon] ; Rumiko Kurosawa [Japon] ; Masaaki Mori [Japon]	Clinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis
000056 (2015)	Yuliya Hellwig [Allemagne] ; Young E. Yoo [Allemagne] ; Marie L. Re [Allemagne] ; Oliver Andres [Allemagne] ; Matthias Braun [Allemagne] ; Paul G. Schlegel [Allemagne] ; Matthias Wölfl [Allemagne]	Fulminant skin GvHD with a cytokine pattern resemblant of cytokine release syndrome successfully treated with multimodal immunosuppression including tocilizumab
000155 (2009)	Misato Hashizume [Japon] ; Naohiko Hayakawa [Japon] ; Miho Suzuki [Japon] ; Masahiko Mihara [Japon]	IL-6/sIL-6R trans-signalling, but not TNF-α induced angiogenesis in a HUVEC and synovial cell co-culture system
000181 (2015)	Yi Zhang [États-Unis] ; Xiaohui Wei [États-Unis] ; Gaurav Bajaj [États-Unis] ; Jeffrey S. Barrett [États-Unis] ; Bernd Meibohm [États-Unis] ; Amita Joshi [États-Unis] ; Manish Gupta [États-Unis]	Challenges and considerations for development of therapeutic proteins in pediatric patients
000195 (2010)	Luciana Breda [Italie] ; Marianna Del Torto [Italie] ; Sara De Sanctis [Italie] ; Francesco Chiarelli [Italie]	Biologics in children’s autoimmune disorders: efficacy and safety
000282 (2010)	Gert Hein [Allemagne] ; Thorsten Eidner [Allemagne] ; Peter Oelzner [Allemagne] ; Michael Rose [Allemagne] ; Alexander Wilke [Allemagne] ; Gunter Wolf [Allemagne] ; Sybille Franke [Allemagne]	Influence of Rituximab on markers of bone remodeling in patients with rheumatoid arthritis: a prospective open-label pilot study
000300 (2012)	Joerg-Patrick Stübgen [États-Unis]	Targeted immunotherapy trials for idiopathic inflammatory myopathies
000394 (2012)	M. Wahle [Allemagne]	Anämie bei Patienten mit rheumatoider Arthritis
000485 (2013)	Maaike Dirckx [Pays-Bas] ; George Groeneweg [Pays-Bas] ; Paul L. A. Van Daele [Pays-Bas] ; Dirk L. Stronks [Pays-Bas] ; Frank J. P. M. Huygen [Pays-Bas]	Mast Cells: A New Target in the Treatment of Complex Regional Pain Syndrome?
000759 (2013)	Till Sörensen [Allemagne] ; Ursula Schulte-Wrede [Allemagne] ; Silvia Pade [Allemagne] ; Heike Hirseland [Allemagne] ; Gerd Burmester [Allemagne] ; Andreas Radbruch [Allemagne] ; Andreas Grützkau [Allemagne] ; Thomas H Upl [Allemagne]	A10.4 Automated and Standardised Analysis for High Dimensional Cytometric Data Provides New Options for Complex Cell-Associated Biomarker Screening
000862 (2011)	Shunichi Shiozawa [Japon] ; Ken Tsumiyama [Japon] ; Kohsuke Yoshida [Japon] ; Akira Hashiramoto [Japon]	Pathogenesis of Joint Destruction in Rheumatoid Arthritis
000A41 (2008)	S. Elitok [Allemagne] ; R. Kettritz [Allemagne]	Pathogenese und Diagnostik von AA-Amyloidosen
000A58 (2013)	L. Unger [Allemagne] ; U. Wollina [Allemagne] ; J. Machetanz [Allemagne] ; C. Stelzner [Allemagne] ; S. Schellong [Allemagne]	Das verfärbte Bein
000A65 (2011)	S. Graf [Allemagne, Niger] ; P.-M. Schumm-Draeger [Allemagne]	Diabetes und Rheuma
000A92 (2012)	Afsha A. Topal [Inde] ; Rachita S. Dhurat [Inde]	Scleroderma therapy: clinical overview of current trends and future perspective
000B17 (2013)	Ravi Iyengar [États-Unis]	Complex diseases require complex therapies
000B67 (2012)	Sandeep Kumar [États-Unis] ; Mark A. Mitchell [États-Unis] ; Bonita Rup [États-Unis] ; Satish K. Singh [États-Unis]	Relationship between potential aggregation‐prone regions and HLA‐DR‐binding T‐cell immune epitopes: Implications for rational design of novel and follow‐on therapeutic antibodies
000C65 (2005)	Masaya Nakamura [Japon] ; Seiji Okada [Japon] ; Yoshiaki Toyama [Japon] ; Hideyuki Okano [Japon]	Role of IL-6 in spinal cord injury in a mouse model
000C81 (2006)	Marcello Maggio [États-Unis] ; Jack M. Guralnik [États-Unis] ; Dan L. Longo [États-Unis] ; Luigi Ferrucci [États-Unis]	Interleukin-6 in Aging and Chronic Disease: A Magnificent Pathway
000E37 (2011)	Meredith A. Atkinson [États-Unis] ; Colin T. White [Canada]	Hepcidin in anemia of chronic kidney disease: review for the pediatric nephrologist

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "complex" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "complex" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    complex
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021